Obstetric outcome in women with polycystic ovarian syndrome

Human Reproduction

Volumn 16, Issue 2, 2001, Pages 226-229

  Mikola, M ^a   Hiilesmaa, V ^a   Halttunen, M ^a   Suhonen, L ^a   Tiitinen, A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gestational diabetes mellitus; Polycystic ovary syndrome; Pre eclampsia; Pregnancy

Indexed keywords

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; NULLIPARA; OBSTETRICS; OUTCOMES RESEARCH; OVARY POLYCYSTIC DISEASE; PERINATAL MORBIDITY; PREDICTION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY RATE; PREMATURE LABOR; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 0035135147     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.2.226     Document Type: Article

References (25)

1. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
2. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease
3. Polycystic ovaries in women with gestational diabetes
4. Cumulative conception and live birth rates after treatment of anovulatory infertility: Safety and efficacy of ovulation induction in 200 patients
5. Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound features in 556 patients
6. Effects of luteinizing hormone, insulin, insulin-like growth factor-1 and insulin-like growth factor-1 binding protein-1 in the polycystic ovary syndrome
7. Higher risk of pre-eclampsia in the polycystic ovary syndrome. A case control study
8. High incidence of pre-eclamptic toxemia in patients with polycystic ovarian disease
9. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
10. Impaired glucose effectiveness in patients with polycystic ovary syndrome
11. Polycystic ovary syndrome: A changing perspective
12. The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: The influence of body weight
13. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance
14. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome - Relation to anthropometric, endocrine and metabolic variables
15. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus
16. Metabolic adjustments in normal and diabetic pregnancy
17. Evidence of high circulating testosterone in women with prior pre-eclampsia
18. Hyperinsulinemia 17 years after pre-eclamptic first pregnancy
19. Insulin secretion in polycystic ovarian disease: Effect of ovarian suppression by GnRH-agonist
20. Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome
21. Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy
22. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome
23. Gestaatiodiabetes, suomen diabetesliiton työryhmän suositus
24. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism
25. Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome